OBJECTIVE: The authors examined the association of treatment preferences with treatment initiation, adherence, and clinical outcome among nonsenior adult and senior primary care patients with depression. METHODS: Sixty primary care participants meeting DSM-IV criteria for major depression were randomly assigned to receive treatment congruent or incongruent with their primary stated preference. Participants received either 20 weeks of escitalopram, with monitoring by a care manager, or 12 weekly sessions of interpersonal psychotherapy followed by two monthly booster sessions. Adherence to treatment and depression severity were reassessed at weeks 4, 8, 12, and 24. RESULTS: Participants expressed stronger preferences for psychotherapy than for antidepressant medication. Preference strength was a more sensitive measure of outcome than was congruence versus incongruence of preference with the assigned treatment. Across age groups, preference strength was significantly associated with treatment initiation and 12-week adherence rate but not with depression severity or remission. CONCLUSIONS: A continuous measure of preference strength may be a more useful measure in clinical practice than preferences per se. Future research should focus on whether and how greater facilitation of the treatment decision-making process between patient and clinician influences clinical outcome.
OBJECTIVE: The authors examined the association of treatment preferences with treatment initiation, adherence, and clinical outcome among nonsenior adult and senior primary care patients with depression. METHODS: Sixty primary care participants meeting DSM-IV criteria for major depression were randomly assigned to receive treatment congruent or incongruent with their primary stated preference. Participants received either 20 weeks of escitalopram, with monitoring by a care manager, or 12 weekly sessions of interpersonal psychotherapy followed by two monthly booster sessions. Adherence to treatment and depression severity were reassessed at weeks 4, 8, 12, and 24. RESULTS: Participants expressed stronger preferences for psychotherapy than for antidepressant medication. Preference strength was a more sensitive measure of outcome than was congruence versus incongruence of preference with the assigned treatment. Across age groups, preference strength was significantly associated with treatment initiation and 12-week adherence rate but not with depression severity or remission. CONCLUSIONS: A continuous measure of preference strength may be a more useful measure in clinical practice than preferences per se. Future research should focus on whether and how greater facilitation of the treatment decision-making process between patient and clinician influences clinical outcome.
Authors: N Bedi; C Chilvers; R Churchill; M Dewey; C Duggan; K Fielding; V Gretton; P Miller; G Harrison; A Lee; I Williams Journal: Br J Psychiatry Date: 2000-10 Impact factor: 9.319
Authors: C Chilvers; M Dewey; K Fielding; V Gretton; P Miller; B Palmer; D Weller; R Churchill; I Williams; N Bedi; C Duggan; A Lee; G Harrison Journal: BMJ Date: 2001-03-31
Authors: Annette M O'Connor; Elizabeth R Drake; George A Wells; Peter Tugwell; Andreas Laupacis; Tom Elmslie Journal: Health Expect Date: 2003-06 Impact factor: 3.377
Authors: Patrick J Raue; Herbert C Schulberg; Martha L Bruce; Samprit Banerjee; Amanda Artis; Maria Espejo; Idalia Catalan; Sara Romero Journal: Am J Geriatr Psychiatry Date: 2019-03-01 Impact factor: 4.105
Authors: Ronald M Epstein; Paul R Duberstein; Mitchell D Feldman; Aaron B Rochlen; Robert A Bell; Richard L Kravitz; Camille Cipri; Jennifer D Becker; Patricia M Bamonti; Debora A Paterniti Journal: J Gen Intern Med Date: 2010-05-15 Impact factor: 5.128
Authors: Francisco Rodriguez-Pulido; Gema Castillo; Sofiane Hamrioui; Laura Delgado Martin; Pilar Vazquez-Beltrán; Isabel de la Torre-Díez; Manuel A Franco-Martín Journal: J Med Syst Date: 2020-02-13 Impact factor: 4.460
Authors: Patrick J Raue; Herbert C Schulberg; Roberto Lewis-Fernandez; Carla Boutin-Foster; Amy S Hoffman; Martha L Bruce Journal: Int J Geriatr Psychiatry Date: 2010-11 Impact factor: 3.485